Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FJXQU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,268
Award facts
- Contract value 100% obligated
- $11,268.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $11,268.23 delivery order on August 26, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract was funded by the Defense Logistics Agency under the Department of Defense and will be fulfilled at the vendor's Conshohocken facility, with an ultimate completion date of August 27, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
This delivery order exemplifies AmerisourceBergen's role as a critical federal pharmaceutical vendor supporting military and veteran healthcare systems. The company's extensive federal contracting portfolio with DLA encompasses numerous therapeutic domains, including endocrinology medications like Ozempic for diabetes management. No set-aside designation was applied to this award, indicating AmerisourceBergen competed successfully in an open procurement environment. The firm fixed-price structure and short performance timeline reflect the streamlined procurement approach typical of delivery orders issued under established indefinite delivery vehicles, enabling the Defense Health Agency and other military healthcare entities to access essential pharmaceutical commodities efficiently.
Quick answers
Who was awarded contract SPE2DB25FJXQU?
SPE2DB25FJXQU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FJXQU worth?
The government has obligated $11,268 on SPE2DB25FJXQU.
Is contract SPE2DB25FJXQU an order under another contract?
Yes. SPE2DB25FJXQU is a delivery order under SPE2DB24D2217, an indefinite delivery contract.
Was contract SPE2DB25FJXQU competed?
The extent of competition for SPE2DB25FJXQU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award